Explore how clinical endpoints are evolving to be more patient-centric for better outcomes in oncologic and cardiometabolic clinical trials.

Discover why embedding patient support services earlier allow for smarter clinical trials by enabling participation and success, as protocols become more complex and expectations...

Explore how sponsors can incorporate MRD across early-phase and registrational development, with a focus on regulatory positioning and clinical pharmacology implications.

This podcast offers practical insights for organizations looking to modernize commercialization strategies and improve patient access in a rapidly changing healthcare landscape.

Geographic atrophy treatments are approved in the US but not Europe due to differing regulatory perspectives on clinical benefit measurement.

As FDA moves toward one pivotal trial approvals, learn how real world evidence can de‑risk development, inform trial design and support regulatory and commercial success.